Geneos Wealth Management’s Oxford Lane Capital OXLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-115,869
Closed -$2.43M 2979
2025
Q2
$2.43M Buy
115,869
+8,666
+8% +$195K 0.06% 333
2025
Q1
$2.53M Buy
107,203
+1,763
+2% +$43.9K 0.08% 273
2024
Q4
$2.67M Buy
105,440
+4,662
+5% +$122K 0.09% 242
2024
Q3
$2.64M Buy
100,778
+1,897
+2% +$51.2K 0.1% 236
2024
Q2
$2.68M Buy
98,881
+65,711
+198% +$1.73M 0.12% 196
2024
Q1
$843K Buy
33,170
+6,650
+25% +$171K 0.04% 381
2023
Q4
$655K Buy
26,520
+2,500
+10% +$61.6K 0.03% 415
2023
Q3
$599K Buy
24,020
+1,300
+6% +$33.5K 0.03% 426
2023
Q2
$550K Buy
22,720
+4,520
+25% +$115K 0.03% 444
2023
Q1
$476K Buy
18,200
+4,000
+28% +$112K 0.03% 454
2022
Q4
$360K Buy
14,200
+3,800
+37% +$98K 0.02% 486
2022
Q3
$268K Sell
10,400
-1,605
-13% -$48.3K 0.02% 531
2022
Q2
$342K Hold
12,005
0.02% 597
2022
Q1
$434K Buy
12,005
+8,000
+200% +$308K 0.02% 570
2021
Q4
$154K Hold
4,005
0.01% 984
2021
Q3
$146K Hold
4,005
0.01% 996
2021
Q2
$151K Hold
4,005
0.01% 977
2021
Q1
$134K Hold
4,005
﹤0.01% 1161
2020
Q4
$125K Buy
4,005
+1,605
+67% +$39.6K 0.01% 1038
2020
Q3
$50K Buy
2,400
+900
+60% +$19.3K ﹤0.01% 1255
2020
Q2
$27K Hold
1,500
﹤0.01% 1493
2020
Q1
$36K Sell
1,500
-40
-3% -$1.54K ﹤0.01% 1250
2019
Q4
$62K Buy
1,540
+1,100
+250% +$48.9K ﹤0.01% 1150
2019
Q3
$20K Buy
440
+40
+10% +$2.02K ﹤0.01% 1608
2019
Q2
$20K Hold
400
﹤0.01% 1633
2019
Q1
$19K Hold
400
﹤0.01% 1603
2018
Q4
$19K Hold
400
﹤0.01% 1524
2018
Q3
$21K Hold
400
﹤0.01% 1552
2018
Q2
$20K Hold
400
﹤0.01% 1449
2018
Q1
$20K Buy
+400
New +$20.2K ﹤0.01% 1395

Other funds holding OXLC

Geneos Wealth Management's OXLC Position: Q3 2025 in Review

Geneos Wealth Management sold out of Oxford Lane Capital (OXLC) in Q3 2025, closing a stake of 115,869 shares — an estimated $2.43M sold.

Geneos Wealth Management first reported a position in OXLC in Q1 2018 and held it in 30 quarters. The position peaked at $2.68M in Q2 2024. 94 funds tracked by Wall St. Rank hold OXLC as of Q3 2025.

  • Geneos Wealth Management reported no remaining Oxford Lane Capital position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 115,869 Oxford Lane Capital shares in Q3 2025, an estimated $2.43M.
  • Geneos Wealth Management first reported a position in Oxford Lane Capital in Q1 2018 and held it in 30 quarters.
  • Geneos Wealth Management's Oxford Lane Capital position peaked at $2.68M in Q2 2024.
  • 94 funds tracked by Wall St. Rank held Oxford Lane Capital as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.